Orbimed Advisors LLC decreased its holdings in shares of C4 Therapeutics, Inc. (NASDAQ:CCCC – Free Report) by 39.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 856,353 shares of the company’s stock after selling 548,549 shares during the quarter. Orbimed Advisors LLC’s holdings in […]

Catalyst Capital Advisors LLC lowered its position in ONEOK, Inc. (NYSE:OKE – Free Report) by 7.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 192,447 shares of the utilities provider’s stock after selling 15,886 shares during the quarter. Catalyst […]